To evaluate the incidence of patients with a positive test for SARS-CoV-2, performed in the preoperative screening for patients treated at the institution
Cohort, prospective, observational study to evaluate the incidence of asymptomatic patients with a positive SARS-CoV-2 test detected in the preoperative screening program of the institution.
Study Type
OBSERVATIONAL
Enrollment
1,500
Screening test for the diagnosis of SARS-CoV-2 in asymptomatic patients
Instituto Brasileiro de Controle do Cancer - IBCC
São Paulo, Brazil
RECRUITINGIncidence of patients with a positive test for SARS-CoV-2, detected in the preoperative screening program
Describe the incidence of patients with a positive test for SARS-CoV-2, detected in the preoperative screening program in our center
Time frame: May- December 2020
Incidence of SARS-CoV-2 infection in the postoperative period in patients with negative screening test;
Describe the incidence of SARS-CoV-2 infection in the postoperative period in patients with negative screening test.
Time frame: Up to 30 days
Postoperative complications
Postoperative complications will be recorded, according to the Clavien-Dindo classification.
Time frame: Up to 30 days
Mortality
To evaluate the risk of all-cause mortality
Time frame: 30 days
Delay in the cancer treatment
Assess the impact of delayed cancer treatment
Time frame: May 2020- March 2021
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.